Sagimet Biosciences, Inc. (SGMT)
10.80
-0.29
(-2.61%)
USD |
NASDAQ |
Sep 21, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences EPS Diluted (Quarterly) : -0.2627 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2627 |
| March 31, 2026 | -0.3271 |
| December 31, 2025 | -0.2942 |
| September 30, 2025 | -0.3976 |
| June 30, 2025 | -0.3226 |
| March 31, 2025 | -0.5646 |
| December 31, 2024 | -0.5032 |
| September 30, 2024 | -0.4548 |
| June 30, 2024 | -0.2544 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.2283 |
| December 31, 2023 | -0.356 |
| September 30, 2023 | -0.2972 |
| June 30, 2023 | -0.3174 |
| March 31, 2023 | -0.3082 |
| June 30, 2022 | -0.3322 |
| March 31, 2022 | -0.4086 |
| March 31, 2021 | -0.2596 |
| March 31, 2020 | -0.1863 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.95M |
| Total Expenses (Quarterly) | 13.95M |
| Enterprise Value | 446.98M |
| Earnings Yield | -11.87% |
| Normalized Earnings Yield | -11.87 |